Habitual use of glucosamine and adverse liver outcomes among patients with type 2 diabetes and MASLD.

Yun ShenYaxin WangJingyi LuYifei MoXiaojing MaGang HuJian Zhou

Published in: Liver international : official journal of the International Association for the Study of the Liver (2024)

The present study indicated that habitual use of glucosamine was associated with a low risk of individual and composite MALOs among patients with type 2 diabetes and MASLD.

Keyphrases

emergency department